A phase I/II study of the combination of indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors.
Yousef Zakharia
No relevant relationships to disclose
Theodore S. Johnson
No relevant relationships to disclose
Howard Colman
Consultant or Advisory Role - Genentech; Roche; Sigma-Tau
Stock Ownership - Castle Biosciences
Honoraria - Merck
Nicholas N. Vahanian
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics
Charles J. Link
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics
Eugene Kennedy
Employment or Leadership Position - Newlink Genetics
Stock Ownership - Newlink Genetics
Ramses F. Sadek
No relevant relationships to disclose
Feng Ming Kong
Research Funding - Varian Medical Systems
John Vender
No relevant relationships to disclose
David Munn
Consultant or Advisory Role - Newlink Genetics
Stock Ownership - Newlink Genetics
Honoraria - Newlink Genetics
Research Funding - Newlink Genetics
Olivier Rixe
No relevant relationships to disclose